Ticker,Title,Link
FGEN,FibroGen to Present at the H.C. Wainwright 26th Annual Global Investment Conference,9/3/2024 10:05:00 PM
FGEN,FibroGen Inc.: Sell Rating Maintained Amid Uncertainties and Limited Upside Potential,8/7/2024 1:26:18 PM
FGEN,FibroGen Reports Second Quarter 2024 Financial Results and Provides Business Update,8/6/2024 10:05:00 PM
FGEN,FibroGen earnings: here's what Wall Street expects,8/5/2024 3:01:13 PM
FGEN,"Weekly Biotech Buzz: FGEN Cuts Jobs, FDA OKs ADAP's Groundbreaking Cell Therapy, ME Rebuffs CEO Bid ",8/4/2024 11:00:05 AM
FGEN,Ground Cinnamon Recalls: What to Know as FDA Issues Alert Over Lead Levels,7/31/2024 3:00:02 PM
FGEN,FibroGen stock plunges 48% post-market on failed drug studies,7/30/2024 10:34:31 PM
FGEN,Goldman Sachs Sticks to Its Sell Rating for FibroGen (FGEN),6/26/2024 7:15:20 PM
FGEN,"FibroGen to Host Part II of Virtual KOL Investor Event Series to Review FG-3246 Development Program in Metastatic Castration-Resistant Prostate Cancer on June 26, 2024",6/18/2024 2:00:00 PM
FGEN,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday,6/4/2024 11:28:06 AM
FGEN,"FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate FibroGen’s Immuno-Oncology Assets, FG-3165 (anti-Galectin 9) and FG-3175 (anti-CCR8), in Combination...",6/3/2024 10:05:00 PM
FGEN,7 Penny Biotech Stocks to Triple Your Investment,5/28/2024 10:10:00 AM
FGEN,FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer...,5/23/2024 11:05:00 PM
FGEN,"NanoViricides, TC BioPharm, Holdco Nuvo among healthcare movers",5/7/2024 2:01:47 PM
FGEN,FibroGen Reports First Quarter 2024 Financial Results,5/6/2024 10:02:00 PM
FGEN,Here's what Wall Street expects from FibroGen's earnings,5/5/2024 3:01:13 PM
FGEN,FibroGen Q1 2024 Earnings Preview,5/3/2024 9:20:20 PM
FGEN,FibroGen to Report First Quarter 2024 Financial Results,4/29/2024 1:00:00 PM
FGEN,FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of  FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be...,4/24/2024 10:02:00 PM
FGEN,Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,4/3/2024 7:56:10 PM
FGEN,FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer,4/2/2024 11:46:47 PM
FGEN,FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference,3/26/2024 12:00:00 PM
FGEN,3 Nightmare Nasdaq Stocks Not Worth Holding Another Day,3/20/2024 7:45:00 PM
FGEN,"FGEN, LEXX and SGLY among mid-day movers",3/12/2024 4:21:11 PM
FGEN,FibroGen Appoints Deyaa Adib As CMO ,3/11/2024 12:46:09 PM
FGEN,"HOLO, OCEA and ALPP among pre-market losers",2/27/2024 1:28:05 PM
FGEN,FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results,2/26/2024 10:06:00 PM
FGEN,Notable earnings after Monday's close,2/25/2024 10:35:04 PM
FGEN,FibroGen to Report Fourth Quarter and Full Year 2023 Financial Results,2/20/2024 1:00:00 PM
FGEN,Sell Rating on FibroGen Amid Skepticism Over Clinical Outcomes and Drug Efficacy,2/14/2024 3:45:36 AM
FGEN,"FibroGen To Host Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program in Pancreatic Cancer on February 13, 2024",2/5/2024 1:00:00 PM
FGEN,"KOPN, CAMP and FGEN among mid-day movers",2/2/2024 5:31:34 PM
FGEN,"FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase 2/3 Adaptive Platform Trial for Metastatic Pancreatic Cancer",1/25/2024 1:00:00 PM
FGEN,FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes at American Society of Hematology Annual...,12/9/2023 11:02:00 PM
FGEN,Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session,11/7/2023 7:10:11 PM
FGEN,FibroGen Reports Third Quarter 2023 Financial Results,11/6/2023 10:01:00 PM
FGEN,FibroGen earnings: here's what Wall Street expects,11/5/2023 3:01:13 PM
FGEN,FibroGen to Report Third Quarter 2023 Financial Results,10/23/2023 1:00:00 PM
FGEN,7 Stocks to Sell Before the Axe Falls,10/19/2023 6:38:48 PM
FGEN,Why REX American Resources Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,8/30/2023 7:17:52 PM
FGEN,"FibroGen Announces Topline Results from LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Ambulatory Duchenne Muscular Dystrophy",8/29/2023 10:15:00 PM
FGEN,"BofA downgrades FibroGen to underperform, cites unfavorable catalysts",8/8/2023 8:29:52 PM
FGEN,"FibroGen GAAP EPS of -$0.90 misses by $0.16, revenue of $44.32M beats by $9.53M",8/7/2023 8:28:43 PM
FGEN,Notable earnings after Monday's close,8/6/2023 9:35:20 PM
FGEN,FibroGen gets an interim CEO,7/25/2023 12:20:12 PM
FGEN,FibroGen to cut 32% of U.S. workforce in restructuring plan,7/19/2023 12:00:22 PM
FGEN,Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month,7/18/2023 2:54:14 PM
FGEN,"Stifel downgrades FibroGen to hold, says it's lost confidence in lead drug",6/27/2023 10:10:17 PM
FGEN,"Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Option Care Health (OPCH) and FibroGen (FGEN)",6/26/2023 11:10:25 PM
FGEN,"Catalyst Watch: Fed stress tests, Snowflake event, AMC hearing and Delta guidance",6/23/2023 7:00:37 PM
FGEN,Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,6/7/2023 8:02:22 PM
FGEN,FibroGen raised to buy by Stifel ahead of Phase 3 data for pamrevlumab,6/2/2023 9:34:13 PM
FGEN,FibroGen Announces Positive Data From Phase 3 Study Of Roxadustat For Treatment Of Anemia ,5/18/2023 2:21:15 PM
FGEN,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tonix Pharma (TNXP), ANI Pharmaceuticals (ANIP) and FibroGen (FGEN)",5/9/2023 12:31:35 PM
FGEN,"FibroGen GAAP EPS of -$0.81 misses by $0.02, revenue of $36.16M beats by $4.64M",5/8/2023 8:41:25 PM
FGEN,FibroGen Q1 2023 Earnings Preview,5/7/2023 9:35:00 PM
FGEN,Goldman Sachs Remains a Sell on FibroGen (FGEN),5/5/2023 6:55:05 PM
FGEN,Goldman Sachs Sticks to Their Sell Rating for FibroGen (FGEN),5/2/2023 4:15:05 AM
FGEN,FibroGen gets $150M term-loan financing,5/1/2023 11:43:15 AM
FGEN,"PACW, FGEN and OVID are among after hour movers",4/24/2023 9:17:27 PM
FGEN,Raymond James Reaffirms Their Buy Rating on FibroGen (FGEN),3/15/2023 10:05:38 AM
FGEN,Analyst Ratings for FibroGen,2/28/2023 8:00:37 PM
FGEN,"FibroGen GAAP EPS of -$0.70 beats by $0.25, revenue of $34.37M beats by $10.42M",2/27/2023 9:02:02 PM
FGEN,Notable earnings after Monday's close,2/26/2023 10:35:56 PM
FGEN,FibroGen Q4 2022 Earnings Preview,2/24/2023 10:35:22 PM
FGEN,Akebia jumps 28% after FDA nod for GSK kidney disease therapy,2/2/2023 5:00:30 PM
FGEN,FibroGen Shares Gain As Analyst Creates Bullish Pitch On Pulmonary Fibrosis Opportunity,1/31/2023 7:26:37 PM
FGEN,FibroGen boosted to outperform at Raymond James on idiopathic pulmonary fibrosis candidate,1/26/2023 4:35:49 PM
FGEN,Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session,1/5/2023 7:01:25 PM
FGEN,Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday,11/9/2022 11:08:43 AM
FGEN,Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session,11/8/2022 6:51:49 PM
FGEN,FibroGen Reports Third Quarter 2022 Financial Results,11/7/2022 10:01:00 PM
FGEN,Notable earnings after Monday's close,11/6/2022 9:35:11 PM
FGEN,FibroGen Q3 2022 Earnings Preview,11/4/2022 9:35:41 PM
FGEN,FibroGen to Participate at Stifel 2022 Healthcare Conference,11/1/2022 12:00:00 PM
FGEN,FDA advisory panel backs approval of GSK drug for anemia caused by chronic kidney disease,10/26/2022 10:00:39 PM
FGEN,FibroGen to Report Third Quarter 2022 Financial Results,10/24/2022 1:00:00 PM
FGEN,7 Unknown Biotech Stocks That Could Rocket in 2023,9/23/2022 11:30:49 AM
FGEN,"SHLS, FORM, HOWL and VWE are among after hour movers",9/13/2022 9:25:29 PM
FGEN,"Short Volatility Alert: FibroGen, Inc.",8/31/2022 5:19:08 PM
FGEN,Recap Of Friday's Biotech Catalysts - End Of the Day Summary,8/27/2022 1:52:44 AM
FGEN,"FibroGen Concludes Dosing In Late-Stage Blood Cell Disorder Study, Sees Top-line Data In H1 2023",8/26/2022 2:10:28 PM
FGEN,FibroGen Reports Second Quarter 2022 Financial Results,8/8/2022 10:01:00 PM
FGEN,Notable earnings after Monday's close,8/7/2022 9:35:38 PM
FGEN,FibroGen Q2 2022 Earnings Preview,8/5/2022 9:35:55 PM
FGEN,FibroGen to Report Second Quarter 2022 Financial Results,7/25/2022 1:00:33 PM
FGEN,FibroGen to Participate at William Blair Biotech Focus Conference 2022,7/1/2022 1:00:00 PM
FGEN,Akebia Therapeutics (AKBA) Stock Soars 18% Despite Lack of News,6/29/2022 5:42:31 PM
FGEN,"FibroGen Announces Completion of Patient Enrollment in LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Duchenne Muscular Dystrophy",6/8/2022 1:00:00 PM
FGEN,FibroGen to Present at Jefferies Healthcare Conference,5/26/2022 1:00:00 PM
FGEN,103 Biggest Movers From Yesterday,5/11/2022 12:22:38 PM
FGEN,77 Stocks Moving In Tuesday's Mid-Day Session,5/10/2022 6:01:45 PM
FGEN,FibroGen Reports First Quarter 2022 Financial Results,5/9/2022 10:01:00 PM
FGEN,Notable earnings after Monday's close,5/8/2022 9:35:08 PM
FGEN,FibroGen to Report First Quarter 2022 Financial Results,4/25/2022 1:00:00 PM
FGEN,"FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis",4/20/2022 1:00:00 PM
FGEN,FibroGen Reports Fourth Quarter and Full Year 2021 Financial Results,2/28/2022 10:01:00 PM
FGEN,Notable earnings after Monday's close,2/27/2022 10:35:02 PM
FGEN,FibroGen to Report Fourth Quarter and Full Year 2021 Financial Results,2/14/2022 1:00:00 PM
FGEN,FibroGen to Present at SVB Leerink 11th Annual Global Healthcare Conference,2/4/2022 1:00:00 PM
FGEN,FibroGen to Present at H.C. Wainwright Bioconnect Virtual Conference,1/4/2022 1:00:00 PM
FGEN,FibroGen Exercises Exclusive License Option for HiFiBiO’s CCR8 Program,12/20/2021 2:00:00 PM
FGEN,"ASMB, FRLN and SABRP among after hour movers",11/24/2021 10:00:37 PM
FGEN,FibroGen Reports Third Quarter 2021 Financial Results,11/9/2021 10:01:00 PM
FGEN,FibroGen Q3 2021 Earnings Preview,11/8/2021 10:35:14 PM
FGEN,"TLRY,PGEN and FGEN among after hour movers",11/5/2021 9:00:21 PM
FGEN,FibroGen to Present at Upcoming Investor Conferences,11/2/2021 12:00:00 PM
FGEN,FibroGen Inc hosts conference call for investors,10/29/2021 3:02:46 PM
FGEN,FibroGen to Report Third Quarter 2021 Financial Results,10/26/2021 1:00:00 PM
FGEN,FibroGen Announces Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week 2021,10/25/2021 1:00:00 PM
FGEN,"The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout",10/5/2021 2:01:45 PM
FGEN,"The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data",9/23/2021 1:56:57 PM
FGEN,What 4 Analyst Ratings Have To Say About FibroGen,9/22/2021 6:35:38 PM
FGEN,"The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data",9/21/2021 2:20:50 PM
FGEN,"The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration",8/27/2021 1:35:25 PM
FGEN,FibroGen's Roxadustat Aces Chemo-Induced Anemia Trial,8/25/2021 7:26:11 PM
FGEN,58 Biggest Movers From Friday,8/23/2021 11:06:17 AM
FGEN,38 Stocks Moving In Friday's Mid-Day Session,8/20/2021 6:00:11 PM
FGEN,"The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck",8/19/2021 1:37:27 PM
FGEN,"The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline",8/18/2021 1:37:56 PM
FGEN,"The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business",8/17/2021 2:28:53 PM
FGEN,FibroGen Announces Retirement of Pat Cotroneo and Appointment of Juan Graham as Chief Financial Officer,8/16/2021 1:00:00 PM
FGEN,"The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO",8/13/2021 1:43:02 PM
FGEN,"The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma",8/12/2021 2:09:26 PM
FGEN,"The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering",8/11/2021 2:14:38 PM
FGEN,10 Biggest Price Target Changes For Tuesday,8/10/2021 1:57:32 PM
FGEN,FibroGen Reports Second Quarter 2021 Financial Results,8/9/2021 10:01:00 PM
FGEN,Notable earnings after Monday's close,8/8/2021 9:35:00 PM
FGEN,FibroGen earnings: here's what to expect,8/7/2021 3:01:21 PM
FGEN,FibroGen to Report Second Quarter 2021 Financial Results,7/29/2021 1:00:00 PM
FGEN,"The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts",7/27/2021 1:48:33 PM
FGEN,FibroGen Out-Licenses Recombinant Human Collagen-Based Biosynthetic Cornea,7/19/2021 2:29:07 PM
FGEN,"The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs",7/18/2021 4:25:56 PM
FGEN,Mid-Afternoon Market Update: Dow Tumbles Over 200 Points; Aehr Test Systems Shares Spike Higher,7/16/2021 8:36:16 PM
FGEN,"The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs",7/15/2021 2:07:56 PM
FGEN,What 3 FibroGen Analysts Are Expecting From Thursday's Roxadustat Adcom Verdict,7/14/2021 11:04:12 PM
FGEN,FibroGen slides after FDA posted documents ahead of AdCom meeting on Roxadustat,7/13/2021 2:33:45 PM
FGEN,"FibroGen Appoints John Hunter, Ph.D. as Chief Scientific Officer",7/12/2021 1:00:00 PM
FGEN,"The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix",7/11/2021 10:45:12 PM
FGEN,Seeking Alpha Catalyst Watch,7/9/2021 7:30:55 PM
FGEN,Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates,7/1/2021 11:07:05 PM
FGEN,Astellas Receives Positive CHMP Opinion for EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease,6/25/2021 3:15:00 PM
FGEN,Biotech Stocks Facing FDA Decision In July 2021 ,6/24/2021 7:42:17 AM
FGEN,14 Biotech Stocks To Watch Over The Next 6 Months,6/23/2021 6:44:55 PM
FGEN,"The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme",6/17/2021 2:31:50 PM
FGEN,Pamrevlumab Included in Pancreatic Cancer Action Network’s Adaptive Clinical Trial Platform,6/16/2021 2:00:00 PM
FGEN,"SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in FibroGen, Inc. of Class Action Lawsuit and Upcoming Deadline - FGEN",6/11/2021 5:57:00 AM
FGEN,FibroGen to Present at Upcoming Investor Conferences,5/27/2021 1:00:00 PM
FGEN,FibroGen Reports First Quarter 2021 Financial Results,5/10/2021 10:01:00 PM
FGEN,Notable earnings after Monday's close,5/9/2021 9:35:00 PM
FGEN,FibroGen to Report First Quarter 2021 Financial Results,5/3/2021 1:00:00 PM
FGEN,FibroGen to Present at Upcoming Investor Conference,4/28/2021 1:00:00 PM
FGEN,FibroGen Receives Rare Pediatric Disease Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy,4/15/2021 1:00:00 PM
FGEN,FibroGen wins FDA’s fast track designation for experimental DMD therapy,4/12/2021 4:35:18 PM
FGEN,The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight,4/10/2021 3:20:43 PM
FGEN,"The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs",4/9/2021 1:26:03 PM
FGEN,"The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data",4/8/2021 2:14:49 PM
FGEN,FibroGen plunges 43% after the company says there were errors in safety analyses data for its anemia drug candidate,4/7/2021 10:30:03 PM
FGEN,FibroGen Provides Additional Information on Roxadustat,4/6/2021 10:01:00 PM
FGEN,FibroGen surges as BofA upgrade stock expecting Roxadustat approval,3/31/2021 4:58:29 PM
FGEN,Fibrogen surged ahead of FDA action date for Roxadustat,3/19/2021 8:47:06 PM
FGEN,3 Biotech Stocks That Could Double In 12 Months,3/17/2021 2:15:17 PM
FGEN,FibroGen starts late-stage study for Duchenne muscular dystrophy therapy,3/16/2021 4:55:13 PM
FGEN,"Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations",3/14/2021 1:14:58 PM
FGEN,Seeking Alpha Catalyst Watch,3/12/2021 8:30:12 PM
FGEN,61 Biggest Movers From Yesterday,3/3/2021 9:17:37 AM
FGEN,Mid-Afternoon Market Update: Crude Oil Down 1.5%; Communication Systems Shares Spike Higher,3/2/2021 8:57:46 PM
FGEN,10 Stocks Moving In Monday's After-Hours Session,3/1/2021 11:04:01 PM
FGEN,Notable earnings after Monday's close,2/28/2021 10:35:00 PM
FGEN,"The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings",2/27/2021 5:58:02 PM
FGEN,FibroGen to Report Fourth Quarter and Full Year 2020 Financial Results,2/18/2021 1:00:00 PM
FGEN,"The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed",2/12/2021 2:10:51 PM
FGEN,"The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement",2/9/2021 2:10:28 PM
FGEN,"Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2021",2/1/2021 4:03:41 PM
FGEN,FibroGen announces supply deal for roxadustat with Astellas,1/27/2021 4:16:59 PM
FGEN,FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2,12/22/2020 1:00:00 PM
FGEN,Mid-Afternoon Market Update: Dow Turns Positive; uniQure Shares Slide,12/21/2020 8:51:09 PM
FGEN,"The Week Ahead In Biotech: Light Calendar In Abbreviated Week Features 1 IPO, 1 FDA Decision",12/20/2020 4:02:46 PM
FGEN,FibroGen Provides Regulatory Update on Roxadustat,12/18/2020 10:59:00 PM
FGEN,Seeking Alpha Catalyst Watch,12/11/2020 8:30:29 PM
FGEN,FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual Meeting,12/2/2020 1:00:00 PM
FGEN,"FibroGen Announces Retirement of K. Peony Yu, M.D., and Appointment of Mark Eisner, M.D., M.P.H. as Chief Medical Officer",12/1/2020 2:00:00 PM
FGEN,Biotech Stocks Facing FDA Decision In December 2020 ,11/30/2020 2:12:00 AM
FGEN,Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis,11/27/2020 1:00:00 PM
FGEN,FibroGen to Present at Upcoming Investor Conferences,11/6/2020 1:00:00 PM
FGEN,FibroGen Reports Third Quarter 2020 Financial Results,11/5/2020 10:01:00 PM
FGEN,Notable earnings after Thursday's close,11/4/2020 10:35:58 PM
FGEN,FibroGen to Report Third Quarter 2020 Financial Results,10/29/2020 12:00:10 PM
FGEN,FibroGen Presents Late-Breaker Abstract Results on Associations between Hemoglobin Levels and Cardiovascular Outcomes in Roxadustat-Treated Patients with Anemia of Chronic Kidney Disease (CKD),10/22/2020 4:08:10 PM
FGEN,FibroGen to Present New Efficacy and Safety Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week 2020 Reimagined,10/14/2020 1:00:10 PM
FGEN,"FibroGen Appoints Percy Carter, MBA, PhD, as Chief Scientific Officer",9/8/2020 1:00:10 PM
FGEN,Stock Alert: FibroGen Rises To New 52-week High ,9/3/2020 4:02:44 PM
FGEN,FibroGen to Present at Upcoming Investor Conferences,9/1/2020 1:00:10 PM
FGEN,FibroGen Announces First Patient Enrolled in Pamrevlumab Phase 3 Clinical Trial in Patients with Duchenne Muscular Dystrophy,8/11/2020 1:00:10 PM
FGEN,FibroGen Reports Second Quarter 2020 Financial Results,8/6/2020 10:02:10 PM
FGEN,What Wall Street expects from FibroGen's earnings,8/5/2020 3:04:13 PM
FGEN,FibroGen to Report Second Quarter 2020 Financial Results,7/23/2020 1:00:10 PM
FGEN,FibroGen Announces First Patient Enrolled in Pamrevlumab Clinical Trial in Patients Hospitalized in U.S. with Acute COVID-19,6/23/2020 1:00:10 PM
FGEN,FibroGen Appoints Thane Wettig as Chief Commercial Officer,6/22/2020 1:00:10 PM
FGEN,FibroGen Announces New Roxadustat Data Presented at 2020 ERA-EDTA Virtual Congress,6/8/2020 11:00:10 PM
FGEN,FibroGen to Present at Upcoming Investor Conferences,5/27/2020 1:00:10 PM
FGEN,European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Roxadustat,5/21/2020 1:00:10 PM
FGEN,FibroGen to Present at Bank of America Securities 2020 Health Care Conference,5/8/2020 1:00:10 PM
FGEN,FibroGen Reports First Quarter 2020 Financial Results,5/7/2020 10:01:10 PM
FGEN,FibroGen To Report First Quarter 2020 Financial Results,4/24/2020 1:00:10 PM
FGEN,UK court rules out FibroGen's patents,4/20/2020 1:27:12 PM
FGEN,FibroGen files for mixed shelf,3/3/2020 4:44:35 AM
FGEN,FibroGen Reports Fourth Quarter and Full Year 2019 Financial Results,3/2/2020 10:01:00 PM
FGEN,Notable earnings after Monday's close,3/1/2020 10:35:51 PM
FGEN,FibroGen to Report Fourth Quarter and Full Year 2019 Financial Results,2/18/2020 1:00:00 PM
FGEN,FDA accepts NDA for FibroGen anemia treatment,2/11/2020 11:08:42 PM
FGEN,7 Big Biotech Stocks to Avoid,1/28/2020 2:46:23 PM
FGEN,FibroGen Names Enrique Conterno as Chief Executive Officer,1/6/2020 1:00:00 PM
FGEN,FibroGen Submits New Drug Application to the U.S. FDA for Roxadustat in Patients With Anemia of Chronic Kidney Disease,12/23/2019 1:00:00 PM
FGEN,FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List,12/2/2019 1:00:00 PM
FGEN,FibroGen Reports Third Quarter 2019 Financial Results,11/11/2019 10:01:00 PM
FGEN,FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease,11/8/2019 8:10:59 PM
FGEN,FibroGen Presents Phase 3 Efficacy and Safety Results for Roxadustat Versus Epoetin Alfa as Treatment of Anemia in Incident Dialysis Patients with Chronic Kidney Disease ,11/7/2019 10:39:54 PM
FGEN,"FDA Says ""Not Now AVEO"", HALO Axes 160 Jobs, RDHL Gets Nod For H.pylori Drug ",11/5/2019 7:30:43 AM
FGEN,"FibroGen To Report Third Quarter 2019 Financial Results on Monday, November 11, 2019",11/4/2019 1:00:00 PM
FGEN,"FibroGen Announces First Patient Dosed in LAPIS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients With Locally Advanced Pancreatic Cancer  ",10/23/2019 1:00:05 PM
FGEN,Roxadustat Global Phase 3 Results for Treatment of Chronic Kidney Disease (CKD) Anemia to be Presented at American Society of Nephrology Kidney Week 2019,10/11/2019 4:58:45 PM
FGEN,"FibroGen Congratulates Dr. William G. Kaelin, Jr., Scientific Advisory Board Member, on Receipt of the 2019 Nobel Prize in Physiology or Medicine",10/7/2019 11:57:46 PM
FGEN,FibroGen Receives One of China Pharmaceutical Industry’s Highest Awards for Clinical Innovation for Roxadustat,10/1/2019 2:00:00 AM
FGEN,FibroGen Announces Publication in the Lancet Respiratory Medicine of Positive Pamrevlumab Efficacy and Safety Data for the Praise Phase 2 Study in Idiopathic Pulmonary Fibrosis,9/30/2019 1:00:00 PM
FGEN,FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment of Anemia in Cancer Patients Receiving Chemotherapy,9/26/2019 1:00:00 PM
FGEN,"Astellas Pharma, FibroGen Announce Approval Of Evrenzo In Japan - Quick Facts ",9/20/2019 9:19:48 AM
FGEN,"Fibrogen Announces Passing of CEO Thomas B. Neff, Scientific Innovator and Pioneering Biopharmaceutical Executive",8/26/2019 2:30:00 PM
FGEN,Roxadustat Approved in China for Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis,8/21/2019 10:11:00 PM
FGEN,FibroGen Reports Second Quarter 2019 Financial Results,8/8/2019 10:05:00 PM
FGEN,FibroGen earnings: here's what to expect,8/6/2019 3:03:03 PM
FGEN,"CORRECTION - FibroGen to Report Second Quarter 2019 Financial Results on Thursday, August 8, 2019",8/2/2019 2:39:45 AM
FGEN,Roxadustat China Phase 3 Trial for Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine (NEJM),7/25/2019 12:53:26 AM
FGEN,"FibroGen Announces First Patient Dosed in ZEPHYRUS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients with Idiopathic Pulmonary Fibrosis",7/22/2019 1:00:00 PM
FGEN,FibroGen to Present Interim Phase 2 Data on Pamrevlumab in Subjects with Duchenne Muscular Dystrophy at the Parent Project Muscular Dystrophy 2019 Annual Conference,6/28/2019 1:00:00 PM
FGEN,FibroGen to Present at the Goldman Sachs 40th Annual Global Healthcare Conference,6/10/2019 1:00:00 PM
FGEN,FibroGen Appoints Suzanne Blaug to Board of Directors,6/5/2019 11:00:00 PM
FGEN,FibroGen Reports First Quarter 2019 Financial Results,5/9/2019 10:44:50 PM
FGEN,FibroGen earnings: here's what to expect,5/7/2019 3:03:14 PM
FGEN,FibroGen to Report First Quarter 2019 Financial Results,5/6/2019 11:00:00 PM
FGEN,FibroGen Receives Orphan Drug Designation from the U.S. FDA For Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy,4/15/2019 1:00:00 PM
FGEN,FibroGen Reports Fourth Quarter and Full Year 2018 Financial Results,2/27/2019 10:08:12 PM
FGEN,What Wall Street expects from FibroGen's earnings,2/25/2019 3:01:48 PM
FGEN,FibroGen Reports Fourth Quarter and Full Year 2018 Financial Results,2/23/2019 5:43:13 AM
FGEN,FibroGen Announces Positive Topline Results from Three Global Phase 3 Trials of Roxadustat for Treatment of Anemia in Patients with Chronic Kidney Disease,12/20/2018 1:00:00 PM
FGEN,"China first to approve AstraZeneca, FibroGen anaemia drug",12/18/2018 12:24:52 PM
FGEN,"FibroGen Appoints Maykin Ho, Ph.D., to Board of Directors",12/6/2018 10:00:00 AM
FGEN,FibroGen Reports Third Quarter 2018 Financial Results,11/8/2018 10:02:00 PM
FGEN,FibroGen earnings: here's what to expect,11/6/2018 3:03:09 PM
FGEN,"FibroGen to Report Third Quarter 2018 Financial Results on Thursday, November 8, 2018",11/2/2018 10:02:51 PM
FGEN,ASN Kidney Week 2018: Data Presented from Two Japanese Phase 3 Studies on Roxadustat in the Treatment of Anemia Associated with Chronic Kidney Disease in Patients on Dialysis,10/30/2018 9:00:00 AM
FGEN,FibroGen Presents Results from Two Phase 3 Studies of Roxadustat for the Treatment of Anemia Associated with Chronic Kidney Disease Conducted in China at American Society of Nephrology Kidney Week...,10/26/2018 1:49:27 AM
FGEN,"Week Ahead In Pharmaceuticals: 11 Stocks To Watch (MRTX, EPZM, ITCI...) ",10/22/2018 10:49:36 AM
FGEN,"CERS Boosts Revenue Outlook, KOOL Hands Out Pink Slips, EIGR'S UTLRA Study Fails ",10/17/2018 8:52:16 AM
FGEN,FibroGen Announces Four Clinical Presentations on Roxadustat at Upcoming American Society of Nephrology Kidney Week 2018 Annual Meeting,10/16/2018 10:27:29 PM
FGEN,Astellas Submits New Drug Application in Japan of Roxadustat for The Treatment of Anemia  Associated with Chronic Kidney Disease in Patients on Dialysis,10/1/2018 2:00:00 PM
FGEN,"ADIL On Track, PGNX Slumps On Phase III Study Failure, VNDA On Watch ",9/13/2018 9:19:01 AM
FGEN,FibroGen Receives Fast Track Designation From the U.S. FDA for Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis,9/12/2018 3:30:00 PM
FGEN,Is There Still Room To Run For These Biotech Stocks? ,9/4/2018 4:48:11 PM
FGEN,FibroGen Reports Second Quarter 2018 Financial Results,8/7/2018 10:02:00 PM
FGEN,FibroGen is about to announce earnings — here's what Wall Street expects,8/5/2018 3:01:59 PM
FGEN,"FibroGen to Report Second Quarter 2018 Financial Results on Tuesday, August 7, 2018Conference Call and Audio Webcast Scheduled for 5:00 p.m. ET (2:00 p.m. PT)",8/1/2018 11:21:44 PM
FGEN,FibroGen Announces Completion of Enrollment in U.S. Phase 3 Clinical Program for Roxadustat in Anemia Associated with Chronic Kidney Disease,6/7/2018 1:00:00 PM
FGEN,FibroGen to Present at Two Upcoming Investor Conferences,6/4/2018 8:05:29 PM
FGEN,FibroGen Presents Latest Data From PRAISE Phase 2b Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis at American Thoracic Society 2018,5/21/2018 10:00:00 PM
FGEN,FibroGen Reports First Quarter 2018 Financial Results,5/9/2018 10:02:00 PM
FGEN,"FibroGen to Report First Quarter 2018 Financial Results on Wednesday, May 9, 2018Conference Call and Audio Webcast Scheduled for 5:00 p.m. ET (2:00 p.m. PT)",5/2/2018 1:00:00 PM
FGEN,BRIEF-Fibrogen Inc CEO's 2017 Compensation Was $7.1 Million,4/24/2018 10:25:34 PM
FGEN,UPDATE - FibroGen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment of Patients with Locally Advanced Unresectable Pancreatic Cancer,3/1/2018 7:45:22 PM
FGEN,FibroGen Reports Fourth Quarter and Full Year 2017 Financial Results,2/27/2018 10:11:09 PM
FGEN,"FibroGen to Report Fourth Quarter and Full Year 2017 Financial Results on Tuesday, February 27, 2018Conference Call and Audio Webcast Scheduled for 5:00 p.m. ET (2:00 p.m. PT)",2/21/2018 1:00:00 PM
FGEN,"OTIC Data Music To Ears, Apellis IPO Opens Today, CAPR High On HOPE ",11/9/2017 7:35:20 AM
FGEN,FibroGen Reports Third Quarter 2017 Financial Results,11/8/2017 10:02:00 PM
FGEN,"FibroGen to Report Third Quarter Financial Results on Wednesday, November 8, 2017Conference Call and Webcast Scheduled for 5:00 p.m. ET (2:00 p.m. PT)",10/31/2017 1:00:00 AM
FGEN,FibroGen Announces Acceptance by China FDA of Roxadustat New Drug Application (NDA) for Treatment of Anemia Associated With Dialysis and Non-Dialysis Chronic Kidney Disease (CKD)Triggers Milestone...,10/18/2017 1:00:00 PM
FGEN,FibroGen Appoints Gerald Lema to Board of Directors,9/19/2017 10:35:35 PM
FGEN,Fibrogen Presents Latest Data From Phase 2b Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis at European Respiratory Society (ERS) International Congress 2017,9/13/2017 1:00:00 PM
FGEN,"ALXN's Strengthening Patents, FOLD's Fabry Drug Approved In OZ, VBIV Surges ",8/16/2017 8:01:41 AM
FGEN,"Biotech Stocks on Investors' Radar -- Dermira, Endocyte, FibroGen, and Global Blood Therapeutics",8/10/2017 1:05:00 PM
FGEN,"Latest R&D Success, FDA Approvals and Significant Advances in Clinical Trials Boosting Biotech Sector",8/9/2017 2:30:00 PM
FGEN,FibroGen's Pamrevlumab Gets Orphan Drug Designation To Treat Pancreatic Cancer ,6/22/2017 6:37:14 AM
FGEN,"How These Biotech Stocks are Faring? -- FibroGen, Bellicum Pharma, Intercept Pharma, and Cellect Biotechnology",4/17/2017 1:00:00 PM
FGEN,"Gainers & Losers Of Apr.6: HTGM, AKTX, FGEN, ARLZ, ADAP... ",4/7/2017 4:17:37 AM
